Home » Topics » BioWorld Science

BioWorld Science
RSS

Cocrystal Pharma presents new antiviral compounds

Nov. 2, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 2, 2021

Mitobridge discloses new CD38 inhibitors

Nov. 2, 2021

GWAS meta-analysis identifies genetic variants linked to vertigo

Nov. 2, 2021

Almirall patents new TYK2 inhibitors

Nov. 2, 2021

Ndufv2 as a sex-specific genetic factor influencing mitochondrial functions

Nov. 2, 2021

FD-223, a novel PI3Kdelta inhibitor with potent activity in models of AML

Nov. 2, 2021

Researchers recapitulate anti-NMDA receptor encephalitis in zebrafish

Nov. 2, 2021

Engineered Salmonella for intracellular delivery of protein drugs to solid tumors

Nov. 2, 2021

Targeting the NOX1-IL-6-secretory phenotype proinflammatory signaling axis can ease cell senescence

Nov. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...